drugset / Trial / NCT05170230

The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations

NCT05170230

Unknown 99 enrolled Wael Elbanna Clinic
RandomizedParallel-groupTriple-blindTreatment

Summary

Our study aims to evaluate the efficacy of intracapsular injection of Terlipressin versus Carbetocin injection on hemoglobin level in women undergoing abdominal laparoscopic myomectomy. Moreover, to evaluate their efficacy in decreasing blood loss on operative time and to describe the injection sequelae for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.

Timeline

Start
2022-02-27
Primary completion
2024-12-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Terlipressin Peptide Other

Indications